These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 11191650

  • 1. Frequency-dependent blockade of T-type Ca2+ current by efonidipine in cardiomyocytes.
    Masumiya H, Kase J, Tanaka Y, Tanaka H, Shigenobu K.
    Life Sci; 2000 Dec 08; 68(3):345-51. PubMed ID: 11191650
    [Abstract] [Full Text] [Related]

  • 2. The R(-)-enantiomer of efonidipine blocks T-type but not L-type calcium current in guinea pig ventricular myocardium.
    Tanaka H, Komikado C, Shimada H, Takeda K, Namekata I, Kawanishi T, Shigenobu K.
    J Pharmacol Sci; 2004 Dec 08; 96(4):499-501. PubMed ID: 15599089
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of myocardial L- and T-type Ca2+ currents by efonidipine: possible mechanism for its chronotropic effect.
    Masumiya H, Shijuku T, Tanaka H, Shigenobu K.
    Eur J Pharmacol; 1998 May 22; 349(2-3):351-7. PubMed ID: 9671117
    [Abstract] [Full Text] [Related]

  • 4. A selective T-type Ca2+ channel blocker R(-) efonidipine.
    Shin MC, Kim CJ, Min BI, Ogawa S, Tanaka E, Akaike N.
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun 22; 377(4-6):411-21. PubMed ID: 18278483
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Identification of R(-)-isomer of efonidipine as a selective blocker of T-type Ca2+ channels.
    Furukawa T, Miura R, Honda M, Kamiya N, Mori Y, Takeshita S, Isshiki T, Nukada T.
    Br J Pharmacol; 2004 Dec 22; 143(8):1050-7. PubMed ID: 15545287
    [Abstract] [Full Text] [Related]

  • 8. Effects of Ca2+ channel antagonists on sinus node: prolongation of late phase 4 depolarization by efonidipine.
    Masumiya H, Tanaka H, Shigenobu K.
    Eur J Pharmacol; 1997 Sep 17; 335(1):15-21. PubMed ID: 9371541
    [Abstract] [Full Text] [Related]

  • 9. T-type Ca2+ channel blockade prevents sudden death in mice with heart failure.
    Kinoshita H, Kuwahara K, Takano M, Arai Y, Kuwabara Y, Yasuno S, Nakagawa Y, Nakanishi M, Harada M, Fujiwara M, Murakami M, Ueshima K, Nakao K.
    Circulation; 2009 Sep 01; 120(9):743-52. PubMed ID: 19687356
    [Abstract] [Full Text] [Related]

  • 10. Efonidipine hydrochloride: a dual blocker of L- and T-type ca(2+) channels.
    Tanaka H, Shigenobu K.
    Cardiovasc Drug Rev; 2002 Sep 01; 20(1):81-92. PubMed ID: 12070536
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Beneficial effects of the dual L- and T-type Ca2+ channel blocker efonidipine on cardiomyopathic hamsters.
    Suzuki S, Ohkusa T, Ono K, Sato T, Yoshida MA, Yano M, Takebayashi S, Matsuzaki M.
    Circ J; 2007 Dec 01; 71(12):1970-6. PubMed ID: 18037756
    [Abstract] [Full Text] [Related]

  • 13. Blocking T-type Ca2+ channels with efonidipine decreased plasma aldosterone concentration in healthy volunteers.
    Okayama S, Imagawa K, Naya N, Iwama H, Somekawa S, Kawata H, Horii M, Nakajima T, Uemura S, Saito Y.
    Hypertens Res; 2006 Jul 01; 29(7):493-7. PubMed ID: 17044661
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Molecular pharmacology of human Cav3.2 T-type Ca2+ channels: block by antihypertensives, antiarrhythmics, and their analogs.
    Perez-Reyes E, Van Deusen AL, Vitko I.
    J Pharmacol Exp Ther; 2009 Feb 01; 328(2):621-7. PubMed ID: 18974361
    [Abstract] [Full Text] [Related]

  • 17. Differential blocking action of dihydropyridine Ca2+ antagonists on a T-type Ca2+ channel (alpha1G) expressed in Xenopus oocytes.
    Furukawa T, Nukada T, Miura R, Ooga K, Honda M, Watanabe S, Koganesawa S, Isshiki T.
    J Cardiovasc Pharmacol; 2005 Mar 01; 45(3):241-6. PubMed ID: 15725949
    [Abstract] [Full Text] [Related]

  • 18. T-type Ca2+ channel blockers prevent cardiac cell hypertrophy through an inhibition of calcineurin-NFAT3 activation as well as L-type Ca2+ channel blockers.
    Horiba M, Muto T, Ueda N, Opthof T, Miwa K, Hojo M, Lee JK, Kamiya K, Kodama I, Yasui K.
    Life Sci; 2008 Mar 12; 82(11-12):554-60. PubMed ID: 18275974
    [Abstract] [Full Text] [Related]

  • 19. Inhibitory effect of efonidipine on aldosterone synthesis and secretion in human adrenocarcinoma (H295R) cells.
    Imagawa K, Okayama S, Takaoka M, Kawata H, Naya N, Nakajima T, Horii M, Uemura S, Saito Y.
    J Cardiovasc Pharmacol; 2006 Jan 12; 47(1):133-8. PubMed ID: 16424797
    [Abstract] [Full Text] [Related]

  • 20. Voltage- and frequency-dependent modulation of L-type Ca2+ channel by MPC-1304, a novel calcium antagonist in guinea-pig hearts.
    Sunami A, Kanno T, Kanda A.
    Arch Int Pharmacodyn Ther; 1995 Jan 12; 330(2):151-64. PubMed ID: 8861709
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.